GlassScriptPhysician profile
Jason T Ortman
NPI 1578545828
$44,661.72
in general payments reported to CMS, 2019-2025
21 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $2,096 · 2021: $2,744 · 2022: $7,100 · 2023: $8,657 · 2024: $1,232 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,700 · Travel and Lodging: $5,254 · Food and Beverage: $4,630 · Consulting Fee: $1,705 · Gift: $400 · Entertainment: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,700.00 |
| Travel and Lodging | $5,253.81 |
| Food and Beverage | $4,630.38 |
| Consulting Fee | $1,705.00 |
| Gift | $400.00 |
| Entertainment | $152.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $26,333.97 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $14,392.43 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $567.62 | 2019-2025 | Acuvue |
| Alcon Research LLC | $475.00 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $470.28 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $427.05 | 2022-2025 | Infuse, Miebo, Xiidra |
| Visionary Optics LLC | $400.00 | 2025 | |
| Abbvie INC. | $230.47 | 2023-2025 | |
| Abb Con-Cise Optical Group LLC | $219.14 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $168.60 | 2019-2022 | |
| Optos, INC. | $152.29 | 2023-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Glaukos Corporation | $151.18 | 2021 | |
| Kala Pharmaceuticals, INC. | $143.10 | 2021 | |
| Maculogix, INC. | $134.17 | 2019 | |
| Astellas Pharma US INC | $114.06 | 2024 | Izervay |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $78.34 | 2019-2020 | |
| Optovue, INC. | $66.67 | 2019 | |
| Oyster Point Pharma, INC. | $61.20 | 2022-2025 | Tyrvaya, Ryzumvi |
| Allergan, INC. | $37.21 | 2022 | |
| Shire North American Group INC | $24.51 | 2019 | |
| Sun Pharmaceutical Industries INC. | $14.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Ortman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.